Brown, J W L, Cunniffe, N G, Prados, F, Kanber, B, Jones, J L, Needham, E, Georgieva, Z, Rog, D, Pearson, O R, Overell, J, Macmanus, D, Samson, R S, Stutters, J, Ffrench-constant, C, Gandini Wheeler-kingshott, C A M, Moran, C, Flynn, P D, Michell, A W, Franklin, R J M, Chandran, S, Altmann, D R, Chard, D T, Connick, P & Coles, A J 2021, ' Safety and efficacy of bexarotene in patients with relapsing-remitting multiple sclerosis (CCMR One): a randomised, double-blind, placebo-controlled, parallel-group, phase 2a study ', The Lancet Neurology, vol. 20, no. 9, pp. 709-720 . https://doi.org/10.1016/S1474-4422(21)00179-4
Lancet Neurology Connick, P, Kolappan, M, Crawley, C, Webber, D J, Patani, R, Michell, A W, Du, M-Q, Luan, S-L, Altmann, D R, Thompson, A J, Compston, A, Scott, M A, Miller, D H & Chandran, S 2012, ' Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis : an open-label phase 2a proof-of-concept study ', Lancet Neurology, vol. 11, no. 2, pp. 150-156 . https://doi.org/10.1016/S1474-4422(11)70305-2